The upgrade from Peer Perform to Outperform by a reputable analyst firm like Wolfe Research indicates a strong positive outlook on Tenet Healthcare's future performance. The new price target of $122 suggests a significant upside potential from current levels, which could attract investor interest and drive the stock price up in the short term.